Literature DB >> 1530898

Determinants of ventricular ectopy in hypertensive cardiac hypertrophy.

R E Schmieder1, F H Messerli.   

Abstract

Left ventricular hypertrophy in arterial hypertension has repeatedly been documented to trigger or aggravate ventricular ectopy. To determine cardiovascular mechanisms underlying ventricular ectopy, we examined 53 hypertensive patients with mild to moderate nondilated left ventricular hypertrophy by 24-hour echocardiographic monitoring and two-dimensional (2-D)-guided M-mode echocardiography. Patients with more severe ectopy (Lown's class II to IV) were older and had greater increases in left ventricular mass, ejection fraction, velocity of circumferential fiber shortening, end-diastolic volume index, and left ventricular stroke work than patients with less severe ectopy (Lown's class 0 to I). Left ventricular mass, end-diastolic diameter, stroke volume, stroke work, ejection rate, velocity of circumferential fiber shortening, and fractional fiber shortening were enhanced in a subgroup with complex ventricular ectopy (multiform or paired premature ventricular beats or runs of ventricular tachycardia) when compared with a subgroup matched with respect to age, sex, body surface area, and mean arterial pressure, which had uniform monofocal ventricular beats occurring with a frequency of less than 10/hr only. Our data indicate that the frequency and severity of ventricular ectopy in patients with essential hypertension is determined by age, severity of left ventricular hypertrophy, chamber volume, and indices of contractility and pump function. Whether or not the pattern of ventricular ectopy will identify hypertensive patients with left ventricular hypertrophy who are at increased risk of sudden death remains to be determined.

Entities:  

Mesh:

Year:  1992        PMID: 1530898     DOI: 10.1016/0002-8703(92)90751-g

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  4 in total

Review 1.  Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk.

Authors:  Goran Koracevic; Milovan Stojanovic; Dragan Lovic; Marija Zdravkovic; Dejan Sakac
Journal:  J Hum Hypertens       Date:  2021-03-02       Impact factor: 3.012

2.  Effect of imidapril and nifedipine on left ventricular hypertrophy in untreated hypertension.

Authors:  Nikant Kumar Sabharwal; Jonathan Swinburn; Avijit Lahiri; Roxy Senior
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

3.  Premature atrial and ventricular complexes in outpatients referred from a primary care facility.

Authors:  Wilma Noia Ribeiro; Alice Tatsuko Yamada; Cesar José Grupi; Gisela Tunes da Silva; Alfredo Jose Mansur
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

4.  Vulnerable myocardial interstitium in patients with isolated left ventricular hypertrophy and sudden cardiac death: a postmortem histological evaluation.

Authors:  Balaji K Tamarappoo; Benjamin T John; Kyndaron Reinier; Carmen Teodorescu; Audrey Uy-Evanado; Karen Gunson; Jonathan Jui; Sumeet S Chugh
Journal:  J Am Heart Assoc       Date:  2012-06-22       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.